team-member

Mr. Nolan is an Independent Director. He spent 15 years with Royal Philips NV, latterly as Head of Mergers & Acquisitions, and has also served as Head of Mergers & Acquisitions at Veon Inc., a major mobile telecoms operator in Emerging Markets. During his time at Philips, he led a series of acquisitions in diagnostic imaging, an area in which Philips is now a global leader. He has extensive quoted-company board experience having served on the boards of M*Modal Inc., Navteq Inc and SHL Telemedicine Ltd. Mr. Nolan graduated from Oxford University in Law in 1983 and is a qualified barrister in England and Wales. He also holds an MBA from INSEAD.

Abbas holds a B.A. in Business Administration from the American University in Cairo.

Dr. Morsy has more than 25 years of experience that cover strategic and operational expertise in the pharmaceutical industry. Dr. Morsy brings to Remedy Healthcare a wide range of experience in finance, business planning and strategy, human resources, product development, sales, and marketing. Before joining Remedy, Dr. Morsy was the country manager of Pfizer Egypt, which he joined in 1995, prior to which, he was a director at Schering-Plough in Saudi Arabia. Dr. Morsy is also the Chief Executive Officer of Remedy’s subsidiary Rameda Pharmaceuticals, a position he has held since 2011. Dr. Morsy holds a B.Sc of Pharmacy degree from Alexandria University and an MBA from Arab Academy for Science and Technology, Alexandria, Egypt.

Mr Bomford is a qualified Chartered Accountant who has spent 24 years with Ernst & Young in a number of roles in the Middle East and East Africa including Abu Dhabi, Riyadh, Dubai and Jeddah. For the last 15 years with Ernst & Young, Jonathan was a partner with a number of international clients across a range of sectors including healthcare, oil, banking and construction. In 2000, Jonathan retired from Ernst & Young and since then has undertaken a number of roles including a Board Member of an Agricultural Trust funding agricultural projects and an Official Mentor providing Business Advice and Services to clients of the Prince’s Trust. Mr. Bomford sits on the Board of NMC Plc as an Independent Non-Executive Director.

In 2010, Shamel Aboul Fadl founded Compass and grew the company to become one of the leading private equity firms in Egypt. Prior to establishing Compass, Shamel Aboul Fadl was a Managing Partner at Pharos Holding, which he helped transform from a boutique investment firm into a full-fledged investment bank. During his tenure at Pharos Holding, Mr. Aboul Fadl launched Pharos Asset Management, where he served as Chief Executive Officer. In 2005, he co-founded Paragon Asset Management, an independent asset manager headquartered in Geneva, Switzerland with AUMs of USD 950 million. Previously, Mr. Aboul Fadl worked with Citigroup in Geneva as Vice President, where he was mandated to grow assets under management with a focus on Egypt and the wider North Africa region. Mr. Aboul Fadl started his career in 1999 with Mansour-Maghraby Investment and Development Company where he specialized in Telecom and IT investments. He is also the Chairman of Bonyan for Development & Trade and sits on the Board of Rameda Pharmaceuticals and on the Board of Trustees of Al Joud Charity Foundation.

Mr. Aboul Fadl holds a B.Sc. in Construction Engineering from the American University in Cairo and an MBA from The Wharton Business School, University of Pennsylvania.

Walid Cherif is the Managing Director and Head of Gulf Credit Partners, an innovative USD 300 million credit business initiative for the MENA and Turkey region. This initiative by Gulf Capital invests in debt products across the whole capital structure, from senior debt to mezzanine and quasi equity instruments. Mr. Cherif has over 18 years of international finance experience acquired in various houses in US, Europe and the Middle East region. Prior to joining Gulf Capital in 2011, Walid was the head of NBK Capital Mezzanine Fund where he made mezzanine investments in companies operating in the Middle East and Turkey region. Walid spent more than 9 years at the International Finance Corporation in Washington DC, Dubai and Istanbul.

Mr. Abbas is Founding Chairman of ADES, an LSE-listed oil services company he founded and played a key role in transforming it into a regional player. He has held managerial positions within the oil and gas industry since 1998, where he co-founded and served as managing director and board member of the Egyptian Chinese Drilling Company (ECDC). Mr. Abbas also serves as a board member of Advansys Systems, a group focusing on the provision of solutions for the oil and gas industry. Beyond oil and gas, Mr. Abbas has led investments in industries including real estate, trade and commercial representation, food and agriculture, and automation engineering. He served previously as Managing Partner at Invensys for Engineering and Services Egypt, a joint venture established in 2004 with Invensys Systems (IES), a FTSE 100 company focusing on outsourcing technology and engineering services worldwide. In 2015, he assumed the role of Chairman of the Board for Advansys Engineering Service & Consultancy. In addition, Mr. Abbas serves as a member of the board at: Rameda Pharmaceuticals, CI Capital, M2, and Bonyan for Development & Trade. Mr. Abbas holds a Bachelor’s Degree in Arts and Mass Communications from the American University in Cairo.